HUP0303243A3 - Carbamate compounds for use in preventing and treating bipolar disorder - Google Patents

Carbamate compounds for use in preventing and treating bipolar disorder

Info

Publication number
HUP0303243A3
HUP0303243A3 HU0303243A HUP0303243A HUP0303243A3 HU P0303243 A3 HUP0303243 A3 HU P0303243A3 HU 0303243 A HU0303243 A HU 0303243A HU P0303243 A HUP0303243 A HU P0303243A HU P0303243 A3 HUP0303243 A3 HU P0303243A3
Authority
HU
Hungary
Prior art keywords
preventing
bipolar disorder
carbamate compounds
treating bipolar
treating
Prior art date
Application number
HU0303243A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HUP0303243A2 publication Critical patent/HUP0303243A2/hu
Publication of HUP0303243A3 publication Critical patent/HUP0303243A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
HU0303243A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing and treating bipolar disorder HUP0303243A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005297 WO2002067921A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
HUP0303243A2 HUP0303243A2 (hu) 2004-01-28
HUP0303243A3 true HUP0303243A3 (en) 2012-07-30

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303243A HUP0303243A3 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing and treating bipolar disorder

Country Status (26)

Country Link
US (1) US6562867B2 (cg-RX-API-DMAC7.html)
EP (1) EP1408953B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276837B2 (cg-RX-API-DMAC7.html)
KR (1) KR100946944B1 (cg-RX-API-DMAC7.html)
CN (1) CN1250215C (cg-RX-API-DMAC7.html)
AT (1) ATE324108T1 (cg-RX-API-DMAC7.html)
BR (1) BR0207644A (cg-RX-API-DMAC7.html)
CA (1) CA2439475C (cg-RX-API-DMAC7.html)
CY (1) CY1105330T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20032300A3 (cg-RX-API-DMAC7.html)
DE (1) DE60210976T2 (cg-RX-API-DMAC7.html)
DK (1) DK1408953T3 (cg-RX-API-DMAC7.html)
ES (1) ES2262801T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303243A3 (cg-RX-API-DMAC7.html)
IL (1) IL157590A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007717A (cg-RX-API-DMAC7.html)
MY (1) MY129304A (cg-RX-API-DMAC7.html)
NO (1) NO20033802L (cg-RX-API-DMAC7.html)
NZ (1) NZ527988A (cg-RX-API-DMAC7.html)
PL (1) PL364638A1 (cg-RX-API-DMAC7.html)
PT (1) PT1408953E (cg-RX-API-DMAC7.html)
RS (1) RS50677B (cg-RX-API-DMAC7.html)
RU (1) RU2300372C2 (cg-RX-API-DMAC7.html)
TW (1) TWI250872B (cg-RX-API-DMAC7.html)
WO (1) WO2002067921A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200307465B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2002067923A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating anxiety disorders
PT1383489E (pt) * 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0211244A (pt) 2001-07-16 2004-07-27 Ortho Mcneil Pharm Inc Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
KR101335941B1 (ko) 2005-06-08 2013-12-04 에스케이바이오팜 주식회사 수면-각성 장애의 치료
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR102014615B1 (ko) * 2013-03-12 2019-08-27 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
BR112019025286A2 (pt) 2017-06-02 2020-06-23 Jazz Pharmaceuticals Ireland Limited Métodos e composições para tratamento de sonolência excessiva
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1056611C (zh) * 1994-06-16 2000-09-20 美国辉瑞有限公司 吡唑并吡啶和吡咯并吡啶,其用途和用于制备它们的中间体
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ20032300A3 (cs) 2005-01-12
YU67803A (sh) 2006-08-17
RS50677B (sr) 2010-06-30
CA2439475A1 (en) 2002-09-06
KR20030087010A (ko) 2003-11-12
HUP0303243A2 (hu) 2004-01-28
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
IL157590A0 (en) 2004-03-28
EP1408953A1 (en) 2004-04-21
NO20033802L (no) 2003-10-22
ZA200307465B (en) 2005-03-17
WO2002067921A1 (en) 2002-09-06
HK1063436A1 (en) 2004-12-31
US6562867B2 (en) 2003-05-13
DE60210976T2 (de) 2007-05-24
DK1408953T3 (da) 2006-08-21
CN1505506A (zh) 2004-06-16
CN1250215C (zh) 2006-04-12
KR100946944B1 (ko) 2010-03-15
JP4276837B2 (ja) 2009-06-10
BR0207644A (pt) 2004-03-09
US20020198257A1 (en) 2002-12-26
RU2003128997A (ru) 2005-03-20
CY1105330T1 (el) 2010-03-03
EP1408953B1 (en) 2006-04-26
MY129304A (en) 2007-03-30
PT1408953E (pt) 2006-07-31
TWI250872B (en) 2006-03-11
ATE324108T1 (de) 2006-05-15
RU2300372C2 (ru) 2007-06-10
PL364638A1 (en) 2004-12-13
JP2004533415A (ja) 2004-11-04
ES2262801T3 (es) 2006-12-01
NO20033802D0 (no) 2003-08-26
CA2439475C (en) 2010-05-18
DE60210976D1 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
GB0203286D0 (en) Cyclobenzaprine for treating generalized anziety disorder and compositions thereof
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
IL160388A0 (en) Topical compositions and methods for treating pain
GB0111872D0 (en) Therapeutic agents and methods
ZA200503967B (en) Agent for preventing or treating neuropathy
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
IL162447A0 (en) Methods for slowing senescence and treating and preventing diseases associated with senescence
GB0110288D0 (en) Composition and treatment method
HUP0303344A3 (en) Carbamate compounds for use in preventing and treating movement disorders
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
HUP0303264A3 (en) Carbamate compounds for use in preventing and treating neurodegenerative disorders
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
HUP0303342A3 (en) Carbamate compounds for use in preventing and treating psychotic disorders
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
HUP0302940A3 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
SG110107A1 (en) Compound and use in treatment
GB0119025D0 (en) Compounds and their therapeutic use
AU2002352925A8 (en) Method for treating and preventing pancreatitis
TWI318876B (en) Carbamate compounds for use in preventing or treating bipolar disorder
PL354111A1 (en) Combined therapy for treating the both depression and anxiety
ZA200307471B (en) Carbamate compounds for use in preventing or treating bipolar disorder.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees